Bayesian Monte Carlo uncertainty analysis of human health risks from animal antimicrobial use in a dinamic model of emerging resistance
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000nab a2200000 i 4500 | ||
| 001 | MAP20071506258 | ||
| 003 | MAP | ||
| 005 | 20080418125022.0 | ||
| 007 | hzruuu---uuuu | ||
| 008 | 041221e20041001usa|||| | |00010|eng d | ||
| 040 | $aMAP$bspa | ||
| 084 | $a931 | ||
| 100 | 1 | $0MAPA20080299149$aCox, Louis Anthony Jr. | |
| 245 | 1 | 0 | $aBayesian Monte Carlo uncertainty analysis of human health risks from animal antimicrobial use in a dinamic model of emerging resistance$cLouis Anthony Cox Jr., Douglas A. Popken |
| 520 | 8 | $aRecent qualitative analyses warm of potential future human health risks from emergence of antibiotics resistance in food-borne pathogens due to the use of similar antimicrobial drugs in both food animals and human medicine. This article applies quantitative risks assessmennt methods to help find out, using human health risk from virginiamycin (VM) and the nearly identical human antimicrobial quinupristin-dalfopristin (QD) as a case study | |
| 650 | 0 | 1 | $0MAPA20080588953$aAnálisis de riesgos |
| 650 | 1 | 1 | $0MAPA20080567262$aSalud pública |
| 650 | 1 | 1 | $0MAPA20080566517$aMicrobiología |
| 650 | 1 | 1 | $0MAPA20080545963$aAnimales |
| 650 | 1 | 1 | $0MAPA20080613969$aEnfermedades infecciosas |
| 650 | 1 | 1 | $0MAPA20080591960$aMétodos de análisis |
| 650 | 1 | 1 | $0MAPA20080608606$aSimulación Monte Carlo |
| 700 | 1 | $0MAPA20080229337$aPopken, Douglas A. | |
| 740 | 0 | $aRisk analysis : an international journal | |
| 773 | 0 | $wMAP20077000345$tRisk analysis : an international journal$dNew York and London$gnº 5, October 2004 ; p. 1153-1164 |